293 related articles for article (PubMed ID: 16171759)
1. Treatment and prevention of atrial fibrillation with non-antiarrhythmic pharmacologic therapy.
Lozano HF; Conde CA; Florin T; Lamas GA
Heart Rhythm; 2005 Sep; 2(9):1000-7. PubMed ID: 16171759
[TBL] [Abstract][Full Text] [Related]
2. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
Lally JA; Gnall EM; Seltzer J; Kowey PR
J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
[TBL] [Abstract][Full Text] [Related]
3. Upstream effect for atrial fibrillation: still a dilemma?
Calò L; Martino A; Sciarra L; Ciccaglioni A; De Ruvo E; De Luca L; Sette A; Giunta G; Lioy E; Fedele F
Pacing Clin Electrophysiol; 2011 Jan; 34(1):111-28. PubMed ID: 21029134
[TBL] [Abstract][Full Text] [Related]
4. [Non-channel drugs to prevent atrial fibrillation].
Fazekas T; Liszkai G
Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
[TBL] [Abstract][Full Text] [Related]
5. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
Savelieva I; Kakouros N; Kourliouros A; Camm AJ
Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
[TBL] [Abstract][Full Text] [Related]
6. Drug therapy for atrial fibrillation.
Conway EL; Musco S; Kowey PR
Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy for atrial fibrillation.
Mohammed KS; Kowey PR; Musco S
Future Cardiol; 2010 Jan; 6(1):67-81. PubMed ID: 20014988
[TBL] [Abstract][Full Text] [Related]
9. Association between the use of non-antiarrhythmic drugs and postoperative atrial fibrillation.
Ozaydin M; Turker Y; Peker O; Erdogan D; Varol E; Dogan A; Ibrisim E
Int J Cardiol; 2010 Oct; 144(2):304-6. PubMed ID: 19282043
[TBL] [Abstract][Full Text] [Related]
10. Novel therapeutic options in the prevention of atrial fibrillation.
Archontakis S; Sideris S
Hellenic J Cardiol; 2018; 59(5):279-280. PubMed ID: 30579978
[No Abstract] [Full Text] [Related]
11. Non-antiarrhythmic drugs to prevent atrial fibrillation.
Moro C; Hernández-Madrid A; Matía R
Am J Cardiovasc Drugs; 2010; 10(3):165-73. PubMed ID: 20524718
[TBL] [Abstract][Full Text] [Related]
12. Clinical update on the management of atrial fibrillation.
Danelich IM; Reed BN; Hollis IB; Cook AM; Rodgers JE
Pharmacotherapy; 2013 Apr; 33(4):422-46. PubMed ID: 23553811
[TBL] [Abstract][Full Text] [Related]
13. The changing face of postoperative atrial fibrillation prevention: a review of current medical therapy.
Mayson SE; Greenspon AJ; Adams S; Decaro MV; Sheth M; Weitz HH; Whellan DJ
Cardiol Rev; 2007; 15(5):231-41. PubMed ID: 17700382
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of atrial fibrillation].
Kirchhof P; Breithardt G
Internist (Berl); 2007 Aug; 48(8):819-29; quiz 830-1. PubMed ID: 17632695
[TBL] [Abstract][Full Text] [Related]
15. Nonantiarrhythmic drug therapy for atrial fibrillation.
Murray KT; Mace LC; Yang Z
Heart Rhythm; 2007 Mar; 4(3 Suppl):S88-90. PubMed ID: 17336893
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacologic treatment of atrial fibrillation].
Lelakowski J
Pol Merkur Lekarski; 2008 Oct; 25(148):303-8. PubMed ID: 19145926
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
18. Non-antiarrhythmic drugs for the prevention of atrial fibrillation: ACEIs, ARBs, statins and PUFAs.
Fauchier L; Pierre B; Clementy N; Babuty D
J Med Liban; 2013; 61(2):105-8. PubMed ID: 24163897
[No Abstract] [Full Text] [Related]
19. Rhythm control for atrial fibrillation: non-channel antiarrhythmic drugs are en vogue.
Van Gelder IC
Cardiovasc Res; 2007 Apr; 74(1):8-10. PubMed ID: 17336952
[No Abstract] [Full Text] [Related]
20. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
